[1]
Camargo, G. et al. 2019. New therapeutic approaches for non-muscle invasive bladder cancer (NMIBC): intravesical use of oncotherad biological response modifier and its association with platelet-rich plasma (PRP). Revista dos Trabalhos de Iniciação Científica da UNICAMP. 27 (nov. 2019), 1–1. DOI:https://doi.org/10.20396/revpibic2720192499.